Literature DB >> 21161883

Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany.

A G Franke1, C Bonertz, M Christmann, M Huss, A Fellgiebel, E Hildt, K Lieb.   

Abstract

INTRODUCTION: The aim of this study was to assess for the first time the prevalence and factors associated with stimulant use exclusively for cognitive enhancement among pupils and university students in Germany.
METHODS: A sample of 1 035 pupils (vocational and grammar schools) in small and big cities and 512 university students of 3 Departments (Medicine, Pharmacy, Economics) completed a questionnaire regarding knowledge and use of stimulants for cognitive enhancement and factors associated with their use.
RESULTS: Lifetime prevalence for use of prescription stimulants (methylphenidate, amphetamines) for cognitive enhancement in pupils was 1.55% and in students 0.78%. Last-year and last-month prevalence rates were significantly lower. 2.42% of pupils and 2.93% of students reported lifetime illicit use of stimulants (amphetamines, cocaine, ecstasy) for cognitive enhancement with lower last-year and last-month rates. Prevalence was higher in male pupils, pupils from vocational schools and pupils with bad marks. DISCUSSION: The illicit use of stimulants for cognitive enhancement is significantly higher than non-medical use of prescription stimulants among pupils and students. Stimulant use is determined by gender, school type, and school marks. The potential risks associated with stimulant use require early awareness and intervention strategies. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21161883     DOI: 10.1055/s-0030-1268417

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  60 in total

1.  Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences.

Authors:  Stefanie Mache; Patrick Eickenhorst; Karin Vitzthum; Burghard F Klapp; David A Groneberg
Journal:  Wien Med Wochenschr       Date:  2012-06-16

2.  Motivations for the nonmedical use of prescription drugs in a longitudinal national sample of young adults.

Authors:  Tess K Drazdowski; Lourah M Kelly; Wendy L Kliewer
Journal:  J Subst Abuse Treat       Date:  2020-04-29

Review 3.  Globalization and cognitive enhancement: emerging social and ethical challenges for ADHD clinicians.

Authors:  Ilina Singh; Angela M Filipe; Imre Bard; Meredith Bergey; Lauren Baker
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

4.  Should physicians prescribe cognitive enhancers to healthy individuals?

Authors:  Cynthia Forlini; Serge Gauthier; Eric Racine
Journal:  CMAJ       Date:  2012-12-17       Impact factor: 8.262

5.  Distinct age-dependent effects of methylphenidate on developing and adult prefrontal neurons.

Authors:  Kimberly R Urban; Barry D Waterhouse; Wen-Jun Gao
Journal:  Biol Psychiatry       Date:  2012-05-19       Impact factor: 13.382

Review 6.  Methylphenidate and the juvenile brain: enhancement of attention at the expense of cortical plasticity?

Authors:  Kimberly R Urban; Wen-Jun Gao
Journal:  Med Hypotheses       Date:  2013-09-17       Impact factor: 1.538

7.  Examining the Frequency of Stimulant Misuse among Patients with Primary Disorders of Hypersomnolence: A Retrospective Cohort Study.

Authors:  William G Mantyh; R Robert Auger; Timothy I Morgenthaler; Michael H Silber; Wendy R Moore
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

8.  Medical Students' Attitudes Towards Pharmacological Cognitive Enhancement With Methylphenidate.

Authors:  Nelly Erasmus; Carla Kotzé
Journal:  Acad Psychiatry       Date:  2020-09-24

9.  If kids ruled the world, how would they stop non-medical use of prescription drugs?

Authors:  Mirsada Serdarevic; Amy Elliott; Catherine W Striley; Linda B Cottler; Vicki Osborne
Journal:  J Health Res       Date:  2020-02-14

10.  Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons.

Authors:  Andreas G Franke; Christiana Bagusat; Pavel Dietz; Isabell Hoffmann; Perikles Simon; Rolf Ulrich; Klaus Lieb
Journal:  BMC Med       Date:  2013-04-09       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.